Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Tobramycin (inhalation use)

EU orphan designation number: EU/3/09/613
Active ingredient: Tobramycin (inhalation use)
Indication: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Sponsor: PARI Pharma GmbH
Moosstraße 3, 82319 Starnberg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Orphan designation EMEA/OD/094/08 (2009)1522 of 27/02/2009
05/11/2010 Change of name and/or address of sponsor EMA/367444/2010
30/05/2011 Change of name and/or address of sponsor EMEA/OD/094/08
19/06/2014 Removal of orphan designation from Community Register